-
1
-
-
84878704250
-
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes
-
Hackett, G., Cole, N., Bhartia, M., et al. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med, 10, 2013, 1612.
-
(2013)
J Sex Med
, vol.10
, pp. 1612
-
-
Hackett, G.1
Cole, N.2
Bhartia, M.3
-
2
-
-
84885371224
-
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss
-
Saad, F., Haider, A., Doros, G., et al. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity, 21, 2013, 1975.
-
(2013)
Obesity
, vol.21
, pp. 1975
-
-
Saad, F.1
Haider, A.2
Doros, G.3
-
3
-
-
84896689377
-
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
-
Traish, A.M., Haider, A., Doros, G., et al. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract, 68, 2014, 314.
-
(2014)
Int J Clin Pract
, vol.68
, pp. 314
-
-
Traish, A.M.1
Haider, A.2
Doros, G.3
-
4
-
-
84897814576
-
Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome
-
Article ID 527470
-
Francomano, D., Lenzi, A., Aversa, A., Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome. Int J Endocrinol, 2014 Article ID 527470.
-
(2014)
Int J Endocrinol
-
-
Francomano, D.1
Lenzi, A.2
Aversa, A.3
-
5
-
-
84856939978
-
Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010
-
Gooren, L.J., Behre, H.M., Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010. Aging Male, 15, 2012, 22.
-
(2012)
Aging Male
, vol.15
, pp. 22
-
-
Gooren, L.J.1
Behre, H.M.2
-
6
-
-
57649176913
-
Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth
-
Morgentaler, A., Traish, A.M., Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol, 55, 2009, 310.
-
(2009)
Eur Urol
, vol.55
, pp. 310
-
-
Morgentaler, A.1
Traish, A.M.2
-
7
-
-
57749088367
-
Testosterone and the prostate: implications for the treatment of hypogonadal men
-
Holyoak, J.D., Crawford, E.D., Meacham, R.B., Testosterone and the prostate: implications for the treatment of hypogonadal men. Curr Urol Rep, 9, 2008, 500.
-
(2008)
Curr Urol Rep
, vol.9
, pp. 500
-
-
Holyoak, J.D.1
Crawford, E.D.2
Meacham, R.B.3
-
8
-
-
54349095266
-
Androgens and prostate cancer risk
-
Wirén, S., Stattin, P., Androgens and prostate cancer risk. Best Pract Res Clin Endocrinol Metab, 22, 2008, 601.
-
(2008)
Best Pract Res Clin Endocrinol Metab
, vol.22
, pp. 601
-
-
Wirén, S.1
Stattin, P.2
-
9
-
-
84867052045
-
Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial
-
Muller, R.L., Gerber, L., Moreira, D.M., et al. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial. Eur Urol, 62, 2012, 757.
-
(2012)
Eur Urol
, vol.62
, pp. 757
-
-
Muller, R.L.1
Gerber, L.2
Moreira, D.M.3
-
10
-
-
39149084101
-
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies
-
Roddam, A.W., Allen, N.E., Appleby, P., et al. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst, 100, 2008, 170.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 170
-
-
Roddam, A.W.1
Allen, N.E.2
Appleby, P.3
-
11
-
-
84888840943
-
A new era of testosterone and prostate cancer: from physiology to clinical implications
-
Khera, M., Crawford, D., Morales, A., et al. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol, 65, 2014, 115.
-
(2014)
Eur Urol
, vol.65
, pp. 115
-
-
Khera, M.1
Crawford, D.2
Morales, A.3
-
12
-
-
84880036090
-
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy
-
Pastuszak, A.W., Pearlman, A.M., Lai, W.S., et al. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol, 190, 2013, 639.
-
(2013)
J Urol
, vol.190
, pp. 639
-
-
Pastuszak, A.W.1
Pearlman, A.M.2
Lai, W.S.3
-
13
-
-
33645794792
-
EAU guidelines on erectile dysfunction: an update
-
Wespes, E., Amar, E., Hatzichristou, D., et al. EAU guidelines on erectile dysfunction: an update. Eur Urol, 49, 2006, 806.
-
(2006)
Eur Urol
, vol.49
, pp. 806
-
-
Wespes, E.1
Amar, E.2
Hatzichristou, D.3
-
14
-
-
84888815889
-
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013
-
Heidenreich, A., Bastian, P.J., Bellmunt, J., et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol, 65, 2014, 124.
-
(2014)
Eur Urol
, vol.65
, pp. 124
-
-
Heidenreich, A.1
Bastian, P.J.2
Bellmunt, J.3
-
15
-
-
63249122661
-
Mortality results from a randomized prostate-cancer screening trial
-
Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360, 2009, 1310.
-
(2009)
N Engl J Med
, vol.360
, pp. 1310
-
-
Andriole, G.L.1
Crawford, E.D.2
Grubb, R.L.3
-
16
-
-
84858212484
-
Prostate-cancer mortality at 11 years of follow-up
-
Schröder, F.H., Hugosson, J., Roobol, M.J., et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med, 366, 2012, 981.
-
(2012)
N Engl J Med
, vol.366
, pp. 981
-
-
Schröder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
17
-
-
84880923151
-
Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes
-
Kaplan, A.L., Hu, J.C., Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Urology, 82, 2013, 321.
-
(2013)
Urology
, vol.82
, pp. 321
-
-
Kaplan, A.L.1
Hu, J.C.2
-
18
-
-
2442543161
-
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
-
Wang, C., Cunningham, G., Dobs, A., et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab, 89, 2004, 2085.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2085
-
-
Wang, C.1
Cunningham, G.2
Dobs, A.3
-
19
-
-
58149512149
-
Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review
-
Shabsigh, R., Crawford, E.D., Nehra, A., et al. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res, 21, 2009, 9.
-
(2009)
Int J Impot Res
, vol.21
, pp. 9
-
-
Shabsigh, R.1
Crawford, E.D.2
Nehra, A.3
-
20
-
-
77954394453
-
Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis
-
Fernández-Balsells, M.M., Murad, M.H., Lane, M., et al. Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab, 95, 2010, 2560.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 2560
-
-
Fernández-Balsells, M.M.1
Murad, M.H.2
Lane, M.3
-
21
-
-
84885423616
-
The effect of androgen-replacement therapy on prostate growth: a systematic review and meta-analysis
-
Cui, Y., Zhang, Y., The effect of androgen-replacement therapy on prostate growth: a systematic review and meta-analysis. Eur Urol, 64, 2013, 811.
-
(2013)
Eur Urol
, vol.64
, pp. 811
-
-
Cui, Y.1
Zhang, Y.2
-
22
-
-
85033679667
-
-
Guidelines on male hypogonadism. Available at Accessed February 2012.
-
Dohle GR, Arver S, Bettocchi C et al: Guidelines on male hypogonadism. Available at www.uroweb.org/gls/pdf/16_Male_Hypogonadism_LR%20II.pdf. Accessed February 2012.
-
-
-
Dohle, G.R.1
Arver, S.2
Bettocchi, C.3
-
23
-
-
56249088599
-
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations
-
Wang, C., Nieschlag, E., Swerdloff, R., et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol, 55, 2009, 121.
-
(2009)
Eur Urol
, vol.55
, pp. 121
-
-
Wang, C.1
Nieschlag, E.2
Swerdloff, R.3
-
24
-
-
84872852291
-
Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment
-
Buvat, J., Maggi, M., Guay, A., et al. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med, 10, 2013, 245.
-
(2013)
J Sex Med
, vol.10
, pp. 245
-
-
Buvat, J.1
Maggi, M.2
Guay, A.3
-
25
-
-
77954409942
-
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
-
Bhasin, S., Cunningham, G.R., Hayes, F.J., et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 95, 2010, 2536.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 2536
-
-
Bhasin, S.1
Cunningham, G.R.2
Hayes, F.J.3
-
26
-
-
67349282280
-
Testosterone and prostate cancer: revisiting old paradigms
-
Isbarn, H., Pinthus, J.H., Marks, L.S., et al. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol, 56, 2009, 48.
-
(2009)
Eur Urol
, vol.56
, pp. 48
-
-
Isbarn, H.1
Pinthus, J.H.2
Marks, L.S.3
-
27
-
-
80051923470
-
Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer
-
Morgentaler, A., Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer. Cancer, 117, 2011, 3885.
-
(2011)
Cancer
, vol.117
, pp. 3885
-
-
Morgentaler, A.1
-
28
-
-
79952698470
-
Testosterone therapy in men with untreated prostate cancer
-
Morgentaler, A., Lipshultz, L.I., Bennett, R., et al. Testosterone therapy in men with untreated prostate cancer. J Urol, 185, 2011, 1256.
-
(2011)
J Urol
, vol.185
, pp. 1256
-
-
Morgentaler, A.1
Lipshultz, L.I.2
Bennett, R.3
-
29
-
-
84876422426
-
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment
-
Morgentaler, A., Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment. BJU Int, 110, 2012, E547.
-
(2012)
BJU Int
, vol.110
, pp. E547
-
-
Morgentaler, A.1
-
30
-
-
67349251251
-
Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth
-
Rinnab, L., Gust, K., Hautmann, R.E., et al. Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth. Urologe A, 48, 2009, 516.
-
(2009)
Urologe A
, vol.48
, pp. 516
-
-
Rinnab, L.1
Gust, K.2
Hautmann, R.E.3
|